Dr Mark Nalder
PhD student
Centre for Health Services Research
Lecturer
Faculty of Medicine
Journal Articles
Kim, H and Nalder, M (2022). CO80 Surrogate Endpoints for Overall Survival in Cutaneous Squamous Cell Carcinoma: A Meta-Regression of Clinical Trials. Value in Health, 25 (12), S33. doi: 10.1016/j.jval.2022.09.159
Kulasinghe, Arutha, Monkman, James, Nalder, Mark, O’Leary, Connor, Ladwa, Rahul and O’Byrne, Ken (2020). Transformation or progression from adenocarcinoma to small cell lung cancer detected by serially tracking mutations in the blood. Reports, 3 (4) 33. doi: 10.3390/reports3040033
Conference Papers
Nalder, Mark, Ladwa, Rahul, Raina, Anant, Burge, Matthew E., Love, Amanda, Pattison, David A., Ramsay, Stuart and Wyld, David (2021). 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in patients with somatostatin-expressing neuroendocrine tumors: a real-world retrospective review of efficacy and safety from an Australian tertiary cancer Center. 2021 ASCO Annual Meeting I, Virtual, 4-8 June 2021. Alexandria, VA USA: American Society of Clinical Oncology. doi: 10.1200/jco.2021.39.15_suppl.e16198
Nalder, Mark and Chern, Boris (2019). Chemotherapy dosing practices in the obese population with solid organ malignancies: a single centre, retrospective audit. Medical Oncology Group of Australia Incorporated 40th Anniversary Annual Scientific Meeting, Leading the Way in Medical Oncology Education, Research and Clinical Practice, Canberra, ACT Australia, 14–16 August 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing.